If the coronavirus pandemic taught the world anything, it was how important healthcare is to everyone. With the virus still posing a serious threat, some people may still be reluctant to visit their regular doctors for checkups. Prevent Cancer Foundation released survey results of more than 1,000 respondents that found about 35% of Americans have missed routine cancer screenings due to COVID-19 fears. Additionally, 43% of Americans have missed medical appointments. That becomes a problem when you have chronic conditions to manage. The lack of proper monitoring could lead to more severe issues down the road or end in a preventable hospital stay.

Although Pfizer Inc. (NYSE:PFE), Moderna Inc. (NASDAQ:MRNA) and Johnson & Johnson (NYSE:JNJ) are making headway with vaccines, the world is still suffering from coronavirus infections. That’s why companies that provide telemedicine and remote patient monitoring home services are so crucial during this time. But it’s not only essential with COVID-19 continuing to spread; telemedicine is a service that can help those in need at any time.

G Medical Innovations (NASDAQ:GMVD) is a mobile and e-health company that provides health monitoring services to patients in need. The company gives both caregivers and patients the tools they need to better manage, monitor and improve patient health and outcomes.

G Medical is led by Dr. Yacov Geva, a well-known pioneer in the industry of medical technologies and remote patient monitoring services. With more than 30 years of experience and knowledge, Dr. Yacov has overseen the submission to and approval by the FDA of 48 different medical devices during his career spent with a number of successful healthcare companies. Dr. Yacov’s vast experience will be instrumental in guiding G Medical and positioning it as a provider of real solutions for people in need of mobile and digital healthcare.

New research shows that 89% of the healthcare systems expanded their services to include remote care technology during the pandemic. And patients expressed a desire to monitor and care for their health needs at home rather than travel to the doctor. Even after the COVID-19 spread wanes, it’s likely that people will want to continue digital and home health monitoring and care.

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.